|
| 37871886 | A Prospective Registry Study of <sup>68</sup>Ga-DOTATATE PET/CT Incorporation Into Treatment Planning of Intracranial Meningiomas. | Int J Radiat Oncol Biol Phys | 2024 |
| 37963810 | A 34-gene expression biomarker predicts meningioma outcomes and radiotherapy responses. | Neuro Oncol | 2024 |
| 37871886 | A Prospective Registry Study of <sup>68</sup>Ga-DOTATATE PET/CT Incorporation Into Treatment Planning of Intracranial Meningiomas. | Int J Radiat Oncol Biol Phys | 2024 |
| 37963810 | A 34-gene expression biomarker predicts meningioma outcomes and radiotherapy responses. | Neuro Oncol | 2024 |
| 36394953 | Superenhancer activation of KLHDC8A drives glioma ciliation and hedgehog signaling. | J Clin Invest | 2023 |
| 36227281 | Hypermitotic meningiomas harbor DNA methylation subgroups with distinct biological and clinical features. | Neuro Oncol | 2023 |
| 36400359 | Mutational Status and Clinical Outcomes Following Systemic Therapy with or without Focal Radiation for Resected Melanoma Brain Metastases. | World Neurosurg | 2023 |
| 36394953 | Superenhancer activation of KLHDC8A drives glioma ciliation and hedgehog signaling. | J Clin Invest | 2023 |
| 37944590 | Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses. | Nat Med | 2023 |
| 37589977 | Molecular Features of Resected Melanoma Brain Metastases, Clinical Outcomes, and Responses to Immunotherapy. | JAMA Netw Open | 2023 |
| 37577659 | Glioma-neuronal circuit remodeling induces regional immunosuppression. | bioRxiv | 2023 |
| 37577529 | Hedgehog target genes regulate lipid metabolism to drive basal cell carcinoma and medulloblastoma. | Res Sq | 2023 |
| 37711972 | Radiotherapy and radiosurgery for meningiomas. | Neurooncol Adv | 2023 |
| 38079020 | "De novo replication repair deficient glioblastoma, IDH-wildtype" is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockade. | Acta Neuropathol | 2023 |
| 37971886 | Multiomic screening of invasive GBM cells reveals targetable transsulfuration pathway alterations. | J Clin Invest | 2023 |
| 37138086 | Glioblastoma remodelling of human neural circuits decreases survival. | Nature | 2023 |
| 37444483 | Post-Surgical Prognosis of Patients with Pineoblastoma: A Systematic Review and Individual Patient Data Analysis with Trends over Time. | Cancers (Basel) | 2023 |
| 36993741 | Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses. | Res Sq | 2023 |
| 36993679 | Merlin<sup>S13</sup> phosphorylation controls meningioma Wnt signaling and magnetic resonance imaging features. | Res Sq | 2023 |
| 37432622 | Radiotherapy for Meningioma. | Adv Exp Med Biol | 2023 |
| 37171636 | Correction: Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas. | Acta Neuropathol | 2023 |
| 36729132 | Even heterozygous loss of CDKN2A/B greatly accelerates recurrence in aggressive meningioma. | Acta Neuropathol | 2023 |
| 37503127 | NOTCH3 drives meningioma tumorigenesis and resistance to radiotherapy. | bioRxiv | 2023 |
| 37546798 | Meningeal solitary fibrous tumor cell states phenocopy cerebral vascular development and homeostasis. | Res Sq | 2023 |
| 37292686 | Spatial genomic, biochemical, and cellular mechanisms drive meningioma heterogeneity and evolution. | Res Sq | 2023 |
| 36723772 | Loss of p16 expression is a sensitive marker of CDKN2A homozygous deletion in malignant meningiomas. | Acta Neuropathol | 2023 |
| 38079020 | "De novo replication repair deficient glioblastoma, IDH-wildtype" is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockade. | Acta Neuropathol | 2023 |
| 37711972 | Radiotherapy and radiosurgery for meningiomas. | Neurooncol Adv | 2023 |
| 37589977 | Molecular Features of Resected Melanoma Brain Metastases, Clinical Outcomes, and Responses to Immunotherapy. | JAMA Netw Open | 2023 |
| 37944590 | Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses. | Nat Med | 2023 |
| 37546798 | Meningeal solitary fibrous tumor cell states phenocopy cerebral vascular development and homeostasis. | Res Sq | 2023 |
| 37577659 | Glioma-neuronal circuit remodeling induces regional immunosuppression. | bioRxiv | 2023 |
| 37503127 | NOTCH3 drives meningioma tumorigenesis and resistance to radiotherapy. | bioRxiv | 2023 |
| 37577529 | Hedgehog target genes regulate lipid metabolism to drive basal cell carcinoma and medulloblastoma. | Res Sq | 2023 |
| 37971886 | Multiomic screening of invasive GBM cells reveals targetable transsulfuration pathway alterations. | J Clin Invest | 2023 |
| 37292686 | Spatial genomic, biochemical, and cellular mechanisms drive meningioma heterogeneity and evolution. | Res Sq | 2023 |
| 36993741 | Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses. | Res Sq | 2023 |
| 36993679 | Merlin<sup>S13</sup> phosphorylation controls meningioma Wnt signaling and magnetic resonance imaging features. | Res Sq | 2023 |
| 37444483 | Post-Surgical Prognosis of Patients with Pineoblastoma: A Systematic Review and Individual Patient Data Analysis with Trends over Time. | Cancers (Basel) | 2023 |
| 37171636 | Correction: Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas. | Acta Neuropathol | 2023 |
| 37138086 | Glioblastoma remodelling of human neural circuits decreases survival. | Nature | 2023 |
| 37432622 | Radiotherapy for Meningioma. | Adv Exp Med Biol | 2023 |
| 36723772 | Loss of p16 expression is a sensitive marker of CDKN2A homozygous deletion in malignant meningiomas. | Acta Neuropathol | 2023 |
| 36400359 | Mutational Status and Clinical Outcomes Following Systemic Therapy with or without Focal Radiation for Resected Melanoma Brain Metastases. | World Neurosurg | 2023 |
| 36729132 | Even heterozygous loss of CDKN2A/B greatly accelerates recurrence in aggressive meningioma. | Acta Neuropathol | 2023 |
| 36227281 | Hypermitotic meningiomas harbor DNA methylation subgroups with distinct biological and clinical features. | Neuro Oncol | 2023 |
| 34111427 | Sterol regulation of developmental and oncogenic Hedgehog signaling. | Biochem Pharmacol | 2022 |
| 35772444 | <sup>68</sup>Ga-DOTATATE PET: The Future of Meningioma Treatment. | Int J Radiat Oncol Biol Phys | 2022 |
| 35594891 | Adverse radiation effect and freedom from progression following repeat stereotactic radiosurgery for brain metastases. | J Neurosurg | 2022 |
| 36303473 | Supervised machine learning algorithms demonstrate proliferation index correlates with long-term recurrence after complete resection of WHO grade I meningioma. | J Neurosurg | 2022 |